MILK-BASED DIETETIC COMPOSITION AND USE THEREOF FOR THE TREATMENT OF EXCESS WEIGHT, OBESITY OR METABOLIC SYNDROME
The present invention relates to a milk-based dietetic composition comprising: - proteins in a proportion of from 4.5% to 15.0% by weight relative to the total weight of said dietetic composition, and - fats in a proportion of from 3.5% to 12.5% by weight relative to the total weight of said dieteti...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DABADIE, HENRY |
| description | The present invention relates to a milk-based dietetic composition comprising: - proteins in a proportion of from 4.5% to 15.0% by weight relative to the total weight of said dietetic composition, and - fats in a proportion of from 3.5% to 12.5% by weight relative to the total weight of said dietetic composition, said fats comprising myristic acid, palmitic acid and stearic acid, such that: the myristic acid represents 0.4% to 2.5% by weight relative to the total weight of said dietetic composition, the palmitic acid represents 1.25% to 3.5% by weight relative to the total weight of said dietetic composition, and the stearic acid represents 0.3% to 0.7% by weight relative to the total weight of said dietetic composition, wherein said myristic acid is preferably in the sn-2 position on the triglycerides, of use in particular in the treatment of excess weight, obesity and/or metabolic syndrome.
La présente invention concerne une composition diététique à base de lait comprenant : - des protéines à raison de 4,5 à 15,0% en poids par rapport au poids total de ladite composition diététique, et, - des matières grasses à raison de 3,5 à 12,5% en poids par rapport au poids total de ladite composition diététique, lesdites matières grasses comprenant de l'acide myristique, de l'acide palmitique et de l'acide stéarique, tels que : l'acide myristique représente 0,4 à 2,5% en poids par rapport au poids total de ladite composition diététique, l'acide palmitique représente 1,25 à 3,5% en poids par rapport au poids total de ladite composition diététique, et, l'acide stéarique représente 0,3 à 0,7% en poids par rapport au poids total de ladite composition diététique, ledit acide myristique de préférence en position sn-2 sur les triglycérides, utile en particulier pour le traitement de la surcharge pondérale, de l'obésité et/ou du syndrome métabolique. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009112778A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009112778A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009112778A13</originalsourceid><addsrcrecordid>eNqNjMEKwjAQRHvxIOo_LHi10NZD9ZgmWxtsupKs1J5KkXgSrdT_xwh-gKd5DG9mHr2Mro9xIRwqUBoZWUuQZE7kNGtqQDQKzg6BK7RIJZRkvwxsUbDBhiGUeJHoHLSoDxVvgAoM6w6CapBFQXU4dV2jLBlcRrPbcJ_86peLaF0iyyr247P30zhc_cO_-5ayJNmnaZbnO5Fu_7M-0No46A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MILK-BASED DIETETIC COMPOSITION AND USE THEREOF FOR THE TREATMENT OF EXCESS WEIGHT, OBESITY OR METABOLIC SYNDROME</title><source>esp@cenet</source><creator>DABADIE, HENRY</creator><creatorcontrib>DABADIE, HENRY</creatorcontrib><description>The present invention relates to a milk-based dietetic composition comprising: - proteins in a proportion of from 4.5% to 15.0% by weight relative to the total weight of said dietetic composition, and - fats in a proportion of from 3.5% to 12.5% by weight relative to the total weight of said dietetic composition, said fats comprising myristic acid, palmitic acid and stearic acid, such that: the myristic acid represents 0.4% to 2.5% by weight relative to the total weight of said dietetic composition, the palmitic acid represents 1.25% to 3.5% by weight relative to the total weight of said dietetic composition, and the stearic acid represents 0.3% to 0.7% by weight relative to the total weight of said dietetic composition, wherein said myristic acid is preferably in the sn-2 position on the triglycerides, of use in particular in the treatment of excess weight, obesity and/or metabolic syndrome.
La présente invention concerne une composition diététique à base de lait comprenant : - des protéines à raison de 4,5 à 15,0% en poids par rapport au poids total de ladite composition diététique, et, - des matières grasses à raison de 3,5 à 12,5% en poids par rapport au poids total de ladite composition diététique, lesdites matières grasses comprenant de l'acide myristique, de l'acide palmitique et de l'acide stéarique, tels que : l'acide myristique représente 0,4 à 2,5% en poids par rapport au poids total de ladite composition diététique, l'acide palmitique représente 1,25 à 3,5% en poids par rapport au poids total de ladite composition diététique, et, l'acide stéarique représente 0,3 à 0,7% en poids par rapport au poids total de ladite composition diététique, ledit acide myristique de préférence en position sn-2 sur les triglycérides, utile en particulier pour le traitement de la surcharge pondérale, de l'obésité et/ou du syndrome métabolique.</description><language>eng ; fre</language><subject>DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE ; FOODS OR FOODSTUFFS ; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J ; HUMAN NECESSITIES ; MAKING THEREOF ; MILK OR CHEESE SUBSTITUTES ; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL ; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090917&DB=EPODOC&CC=WO&NR=2009112778A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090917&DB=EPODOC&CC=WO&NR=2009112778A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DABADIE, HENRY</creatorcontrib><title>MILK-BASED DIETETIC COMPOSITION AND USE THEREOF FOR THE TREATMENT OF EXCESS WEIGHT, OBESITY OR METABOLIC SYNDROME</title><description>The present invention relates to a milk-based dietetic composition comprising: - proteins in a proportion of from 4.5% to 15.0% by weight relative to the total weight of said dietetic composition, and - fats in a proportion of from 3.5% to 12.5% by weight relative to the total weight of said dietetic composition, said fats comprising myristic acid, palmitic acid and stearic acid, such that: the myristic acid represents 0.4% to 2.5% by weight relative to the total weight of said dietetic composition, the palmitic acid represents 1.25% to 3.5% by weight relative to the total weight of said dietetic composition, and the stearic acid represents 0.3% to 0.7% by weight relative to the total weight of said dietetic composition, wherein said myristic acid is preferably in the sn-2 position on the triglycerides, of use in particular in the treatment of excess weight, obesity and/or metabolic syndrome.
La présente invention concerne une composition diététique à base de lait comprenant : - des protéines à raison de 4,5 à 15,0% en poids par rapport au poids total de ladite composition diététique, et, - des matières grasses à raison de 3,5 à 12,5% en poids par rapport au poids total de ladite composition diététique, lesdites matières grasses comprenant de l'acide myristique, de l'acide palmitique et de l'acide stéarique, tels que : l'acide myristique représente 0,4 à 2,5% en poids par rapport au poids total de ladite composition diététique, l'acide palmitique représente 1,25 à 3,5% en poids par rapport au poids total de ladite composition diététique, et, l'acide stéarique représente 0,3 à 0,7% en poids par rapport au poids total de ladite composition diététique, ledit acide myristique de préférence en position sn-2 sur les triglycérides, utile en particulier pour le traitement de la surcharge pondérale, de l'obésité et/ou du syndrome métabolique.</description><subject>DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE</subject><subject>FOODS OR FOODSTUFFS</subject><subject>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</subject><subject>HUMAN NECESSITIES</subject><subject>MAKING THEREOF</subject><subject>MILK OR CHEESE SUBSTITUTES</subject><subject>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</subject><subject>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKwjAQRHvxIOo_LHi10NZD9ZgmWxtsupKs1J5KkXgSrdT_xwh-gKd5DG9mHr2Mro9xIRwqUBoZWUuQZE7kNGtqQDQKzg6BK7RIJZRkvwxsUbDBhiGUeJHoHLSoDxVvgAoM6w6CapBFQXU4dV2jLBlcRrPbcJ_86peLaF0iyyr247P30zhc_cO_-5ayJNmnaZbnO5Fu_7M-0No46A</recordid><startdate>20090917</startdate><enddate>20090917</enddate><creator>DABADIE, HENRY</creator><scope>EVB</scope></search><sort><creationdate>20090917</creationdate><title>MILK-BASED DIETETIC COMPOSITION AND USE THEREOF FOR THE TREATMENT OF EXCESS WEIGHT, OBESITY OR METABOLIC SYNDROME</title><author>DABADIE, HENRY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009112778A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2009</creationdate><topic>DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE</topic><topic>FOODS OR FOODSTUFFS</topic><topic>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</topic><topic>HUMAN NECESSITIES</topic><topic>MAKING THEREOF</topic><topic>MILK OR CHEESE SUBSTITUTES</topic><topic>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</topic><topic>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DABADIE, HENRY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DABADIE, HENRY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MILK-BASED DIETETIC COMPOSITION AND USE THEREOF FOR THE TREATMENT OF EXCESS WEIGHT, OBESITY OR METABOLIC SYNDROME</title><date>2009-09-17</date><risdate>2009</risdate><abstract>The present invention relates to a milk-based dietetic composition comprising: - proteins in a proportion of from 4.5% to 15.0% by weight relative to the total weight of said dietetic composition, and - fats in a proportion of from 3.5% to 12.5% by weight relative to the total weight of said dietetic composition, said fats comprising myristic acid, palmitic acid and stearic acid, such that: the myristic acid represents 0.4% to 2.5% by weight relative to the total weight of said dietetic composition, the palmitic acid represents 1.25% to 3.5% by weight relative to the total weight of said dietetic composition, and the stearic acid represents 0.3% to 0.7% by weight relative to the total weight of said dietetic composition, wherein said myristic acid is preferably in the sn-2 position on the triglycerides, of use in particular in the treatment of excess weight, obesity and/or metabolic syndrome.
La présente invention concerne une composition diététique à base de lait comprenant : - des protéines à raison de 4,5 à 15,0% en poids par rapport au poids total de ladite composition diététique, et, - des matières grasses à raison de 3,5 à 12,5% en poids par rapport au poids total de ladite composition diététique, lesdites matières grasses comprenant de l'acide myristique, de l'acide palmitique et de l'acide stéarique, tels que : l'acide myristique représente 0,4 à 2,5% en poids par rapport au poids total de ladite composition diététique, l'acide palmitique représente 1,25 à 3,5% en poids par rapport au poids total de ladite composition diététique, et, l'acide stéarique représente 0,3 à 0,7% en poids par rapport au poids total de ladite composition diététique, ledit acide myristique de préférence en position sn-2 sur les triglycérides, utile en particulier pour le traitement de la surcharge pondérale, de l'obésité et/ou du syndrome métabolique.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2009112778A1 |
| source | esp@cenet |
| subjects | DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES MAKING THEREOF MILK OR CHEESE SUBSTITUTES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES |
| title | MILK-BASED DIETETIC COMPOSITION AND USE THEREOF FOR THE TREATMENT OF EXCESS WEIGHT, OBESITY OR METABOLIC SYNDROME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T22%3A24%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DABADIE,%20HENRY&rft.date=2009-09-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009112778A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |